TA-65® Science & Research
Here you will find everything about TA-65 products. Studies, interesting articles or exciting findings.
Study on TA-65® and telomerase after a heart attack
A controlled pilot study of 90 elderly patients investigated TA-65® following a heart attack. The focus was on inflammatory markers...
TA-65®: Current studies on telomere length and safety
A 2025 meta-analysis of eight randomized controlled trials examines clinical data on TA-65®, telomere length, and safety. We provide a...
TA-65® and COPD: Research Insights
A preclinical study investigated TA-65® in a mouse model with cigarette smoke-induced small airway changes. We summarize the results and...
TA-65® in the mouse model: telomeres and age-related health markers
A preclinical study investigated TA-65® in cell and mouse models. The focus was on telomerase activity, short telomeres, and various...
TA-65® and Macular Degeneration: Results of a Pilot Study
A randomized, double-blind pilot study investigated TA-65® in 38 individuals with early age-related macular degeneration. We summarize the study design,...
Telomeres and immune aging: What does the research show?
Telomeres and telomerase play an important role in immunosenescence. We explain how T cells, B cells, and natural killer cells...
Anti-Aging and Science: A Critical Assessment
How reliable are claims about anti-aging? We classify the scientific evidence and examine, in particular, the research on TA-65®, telomeres,...
Telomeres, cell aging, and cancer: What does the research say?
Telomeres and telomerase play an important role in both cell aging and cancer biology. This article explains the complex relationships...
Telomerase activation and antiviral function of CD8⁺ T cells
A laboratory study investigated how the experimental telomerase activator TAT2 affects the function of human CD8⁺ T cells. The focus...
Telomere diseases: causes and effects
Telomere diseases are caused by disturbances in telomere maintenance and can affect the bone marrow, lungs, liver, and immune system,...
